Free provider profile
GLEN VANDERSCHAAF, NP
MUSKEGON, MI
Find similar providers: Nurse Practitioner, Family in MUSKEGON, MI
Practice contact details
Source: CMS NPPES · published practice information
Practice phone
231-672-6740
Fax
231-672-6787
Practice address
1150 E SHERMAN BLVD STE 1175, MUSKEGON, MI, 49444
- Registry updated
- 2021-12-08
- NPI issued
- 2019-03-12
- RepVector retrieved
- 11/22/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Specialties & registration
CMS NPPES taxonomy classifications · not verification of certification or services offered
Nurse Practitioner, Family
363LF0000X
Primary
1 registered practice location · A registry listing does not establish active practice, referral relationships or insurance participation.
Need more providers like GLEN VANDERSCHAAF?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What GLEN VANDERSCHAAF prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Eliquis
- Myrbetriq
- Xarelto
- Jardiance
- Stiolto Respimat
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
5,541
Medicare patients
596
Part D drug cost
$434,433
Brand-name share
10.6%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Eliquis (Apixaban) | 123 | $136,323 |
| Myrbetriq (Mirabegron) | 36 | $25,617 |
| Trulicity (Dulaglutide) | 16 | $23,081 |
| Jardiance (Empagliflozin) | 23 | $23,010 |
| Xarelto (Rivaroxaban) | 30 | $22,901 |
| Entresto (Sacubitril/Valsartan) | 13 | $16,037 |
| Farxiga (Dapagliflozin Propanediol) | 16 | $15,488 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | 18 | $8,410 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across MI — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
